Andrew D. Ashe - 14 May 2024 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
President, Chief Operating Officer
Signature
/s/ Andrew Ashe
Issuer symbol
VERV
Transactions as of
14 May 2024
Net transactions value
+$475,760
Form type
4
Filing time
15 May 2024, 17:30:07 UTC
Previous filing
16 Feb 2024
Next filing
10 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Purchase $475,760 +76,000 +29% $6.26 342,509 14 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $6.22 to $6.30 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

Remarks:

President, Chief Operating Officer